CME Scorecard | CME GROUP INC.

CME GROUP INC. (CME) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

70/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseCME / S&P -24.84% / 15.20%	LoseCME / S&P 5.10% / 15.00%	LoseCME / S&P 14.13% / 50.40%
2026-Q11/3	WinCME / S&P 10.74% / -4.33%	LoseCME / S&P 7.54% / 11.30%	LoseCME / S&P 17.91% / 27.70%
2025-Q41/3	LoseCME / S&P 1.54% / 2.65%	LoseCME / S&P 6.37% / 9.00%	WinCME / S&P 15.41% / 13.40%
2025-Q31/3	LoseCME / S&P -1.50% / 8.12%	WinCME / S&P 5.84% / 4.61%	LoseCME / S&P 8.52% / 13.45%
2025-Q22/3	LoseCME / S&P 4.37% / 10.94%	WinCME / S&P 11.15% / 4.83%	WinCME / S&P 13.89% / 10.63%
2025-Q13/3	WinCME / S&P 14.80% / -4.27%	WinCME / S&P 11.72% / 4.98%	WinCME / S&P 13.08% / 10.57%
2024-Q43/3	WinCME / S&P 8.38% / 2.41%	WinCME / S&P 9.88% / 5.25%	WinCME / S&P 9.02% / 6.15%
2024-Q33/3	WinCME / S&P 12.82% / 5.89%	WinCME / S&P 13.03% / 5.89%	WinCME / S&P 13.35% / 6.11%
2024-Q22/3	LoseCME / S&P -8.16% / 4.28%	WinCME / S&P 10.69% / 5.38%	WinCME / S&P 10.61% / 5.12%
2024-Q12/3	LoseCME / S&P 2.76% / 10.56%	WinCME / S&P 9.99% / 5.71%	WinCME / S&P 11.55% / 5.59%
2023-Q42/3	LoseCME / S&P 8.38% / 11.69%	WinCME / S&P 11.15% / 6.81%	WinCME / S&P 19.86% / 7.78%
2023-Q33/3	WinCME / S&P 8.64% / -3.27%	WinCME / S&P 7.83% / 7.52%	WinCME / S&P 14.46% / -5.03%
2023-Q21/3	LoseCME / S&P -2.67% / 8.74%	LoseCME / S&P 8.19% / 9.50%	WinCME / S&P 1.99% / -8.57%
2023-Q12/3	WinCME / S&P 14.58% / 7.50%	LoseCME / S&P 6.93% / 10.77%	WinCME / S&P 3.14% / -15.69%
2022-Q41/3	LoseCME / S&P -1.98% / 7.56%	LoseCME / S&P 7.03% / 11.88%	WinCME / S&P 1.51% / -17.99%
2022-Q31/3	LoseCME / S&P -13.03% / -4.88%	LoseCME / S&P 6.85% / 13.47%	WinCME / S&P 8.11% / -1.41%
2022-Q22/3	WinCME / S&P -13.51% / -16.10%	LoseCME / S&P 4.97% / 13.71%	WinCME / S&P 50.28% / 11.04%
2022-Q12/3	WinCME / S&P 4.58% / -4.60%	LoseCME / S&P 3.64% / 15.97%	WinCME / S&P 43.34% / 42.23%
2021-Q41/3	WinCME / S&P 20.31% / 11.03%	LoseCME / S&P -3.97% / 15.00%	LoseCME / S&P 24.19% / 96.40%
2021-Q30/3	LoseCME / S&P -8.65% / 0.58%	LoseCME / S&P -5.74% / 10.77%	LoseCME / S&P 13.00% / 69.42%
2021-Q20/3	LoseCME / S&P 4.57% / 8.55%	LoseCME / S&P -9.93% / 6.58%	LoseCME / S&P -19.31% / 51.81%
2021-Q11/3	WinCME / S&P 12.66% / 6.17%	LoseCME / S&P -11.43% / -1.06%	LoseCME / S&P -19.97% / 7.39%
2020-Q42/3	LoseCME / S&P 10.85% / 12.15%	WinCME / S&P 0.32% / -3.72%	WinCME / S&P -0.68% / -33.42%
2020-Q32/3	LoseCME / S&P 3.46% / 8.93%	WinCME / S&P -0.86% / -2.04%	WinCME / S&P 5.45% / -27.10%
2020-Q22/3	LoseCME / S&P -5.58% / 20.54%	WinCME / S&P 11.47% / -0.46%	WinCME / S&P 29.49% / -27.11%
2020-Q13/3	WinCME / S&P -13.52% / -19.60%	WinCME / S&P 18.96% / 3.47%	WinCME / S&P 24.49% / -14.75%
2019-Q42/3	LoseCME / S&P -3.49% / 9.07%	WinCME / S&P 12.96% / 5.36%	WinCME / S&P 3.32% / 2.99%
2019-Q32/3	WinCME / S&P 9.24% / 1.70%	WinCME / S&P 25.01% / 5.02%	LoseCME / S&P -57.09% / 0.21%
2019-Q22/3	WinCME / S&P 18.38% / 4.30%	WinCME / S&P 16.00% / 6.64%	LoseCME / S&P -60.49% / 8.65%
2019-Q11/3	LoseCME / S&P -12.14% / 13.65%	WinCME / S&P 14.53% / 8.12%	LoseCME / S&P -57.27% / 14.29%
2018-Q42/3	WinCME / S&P 12.01% / -13.52%	WinCME / S&P 18.24% / 9.05%	LoseCME / S&P -52.09% / 18.23%
2018-Q31/3	LoseCME / S&P 4.26% / 7.71%	LoseCME / S&P 8.62% / 10.21%	WinCME / S&P 200.68% / 19.06%
2018-Q22/3	LoseCME / S&P 1.76% / 3.43%	WinCME / S&P 9.72% / 9.03%	WinCME / S&P 165.03% / 14.46%
2018-Q12/3	WinCME / S&P 11.20% / -0.76%	LoseCME / S&P 6.52% / 7.68%	WinCME / S&P 171.00% / 12.46%
2017-Q42/3	WinCME / S&P 10.71% / 6.64%	LoseCME / S&P 1.38% / 7.03%	WinCME / S&P 163.58% / 13.82%
2017-Q31/3	WinCME / S&P 8.90% / 4.48%	LoseCME / S&P 4.62% / 5.68%	LoseCME / S&P 2.80% / 17.57%
2017-Q22/3	WinCME / S&P 6.02% / 3.09%	LoseCME / S&P 2.96% / 4.83%	WinCME / S&P 23.48% / 17.74%
2017-Q12/3	LoseCME / S&P 3.54% / 6.07%	WinCME / S&P 5.03% / 3.67%	WinCME / S&P 21.90% / 13.32%
2016-Q43/3	WinCME / S&P 13.99% / 3.82%	WinCME / S&P 8.07% / 2.09%	WinCME / S&P 23.10% / 7.05%
2016-Q33/3	WinCME / S&P 7.91% / 3.85%	WinCME / S&P 4.23% / 0.20%	WinCME / S&P 15.01% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	CME total return	S&P 500 Total Return Index
Total return	9.52%	20.78%
Annualized return	9.52%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	CME total return	S&P 500 Total Return Index
Total return	73.98%	83.14%
Annualized return	11.71%	12.86%

10Y · 2016-09-01 to 2026-08-27

Metric	CME total return	S&P 500 Total Return Index
Total return	280.10%	319.30%
Annualized return	14.29%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
LPL Financial Holdings Inc. (LPLA)	United States	$23.839B	22.38
StoneX Group Inc. (SNEX)	United States	$8.386B	26.96
Cboe Global Markets, Inc. (CBOE)	United States	$27.926B	18.70
NASDAQ, INC. (NDAQ)	United States	$52.840B	22.52
Intercontinental Exchange, Inc. (ICE)	United States	$88.072B	17.10